Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs.

Filocamo, Giovanni; Minoia, Francesca; Carbogno, Simone; Costi, Stefania; Romano, Micol; Cimaz, Rolando

Filocamo, Giovanni; Minoia, Francesca; Carbogno, Simone; Costi, Stefania; Romano, Micol; Cimaz, Rolando.

Filocamo G; Fondazione IRCCS Cà Granda ospedale Maggiore Policlinico; giovanni.filocamo@policlinico.mi.it.
Minoia F; Fondazione IRCCS Cà Granda ospedale Maggiore Policlinico.
Carbogno S; Fondazione IRCCS Cà Granda ospedale Maggiore Policlinico.
Costi S; ASST G.Pini-CTO.
Romano M; ASST G.Pini-CTO.

J Rheumatol ; 48(8): 1343-1344, 2021 08.

Article in English | MEDLINE | ID: covidwho-1337761

Subject(s)

Antirheumatic Agents; Biological Products; COVID-19; Rheumatic Diseases; Antirheumatic Agents/adverse effects; Biological Products/therapeutic use; Child; Humans; Rheumatic Diseases/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biological Products / Rheumatic Diseases / Antirheumatic Agents / COVID-19 Limits: Child / Humans Language: English Journal: J Rheumatol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google